NEW YORK, Oct. 3, 2022 /PRNewswire/ — The latest market analysis report titled Immunosuppressants Market by Drug Class and Geography – Forecast and Analysis 2022-2026 has been added to Technavio’s catalog. The analysts at Technavio have categorized the global immunosuppressants market as a part of the global pharmaceuticals market. Our report offers an up-to-date analysis of the current market scenario and provides extensive information on the value chain analysis for the immunosuppressants market, which vendors can leverage to gain a competitive advantage during the forecast period. The data available in our value The chain analysis segment can help vendors plan their research and development cost and enhance their offerings during the forecast period.
For more analysis on Vendor Offerings – Read our Sample Report
Immunosuppressants Market Segmentation
- Drug Class
- Corticosteroids: Corticosteroids are used as a first-line treatment of autoimmune hemolytic anemia. Patients with autoimmune hemolytic anemia are mostly treated with low doses of corticosteroids. Patients receiving low doses of corticosteroids for more than six months have a lower incidence of relapse. Hence, the increasing prevalence of autoimmune diseases across the globe is expected to increase the demand for corticosteroids and, thereby, contribute to the growth of the market in focus during the forecast period.
- Monoclonal antibodies
- North America: 38% of the market’s growth will originate from North America during the forecast period. A rise in the number of organ transplants and technological advancement in the healthcare sector coupled with massive investment in research and development will facilitate the immunosuppressants market growth in North America over the forecast period. In addition, rising expenditure on the development of healthcare infrastructure and an increase in the number of road accidents are some of the other factors that are also fostering the growth of the regional market.
- Rest of the World (ROW)
Detail Insights on the impact of each segment and make informed business decisions. Download the Sample Report
Immunosuppressants Market 2022-2026: Vendor Analysis and Scope
- The immunosuppressants market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market.
- To make the most of the opportunities and recover from the post-pandemic impact, market vendors are focusing on extensive product development activities, enhancements of distribution channels, and directing their efforts in the direction of regional expansion.
- The immunosuppressants market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the R&D process, the success rate of the clinical trials, and the prospects of the leading companies.
- Backed with competitive intelligence and benchmarking, our research reports on the immunosuppressants market are designed to provide entry support, customer profile & M&As as well as go-to-market strategy support.
Top Immunosuppressants Market Players are:
- AbbVie Inc.
- Accord Healthcare Ltd.
- Astellas Pharma Inc.
- Belcher Pharmaceuticals LLC
- Bristol Myers Squibb Co.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Intas Pharmaceuticals Ltd.
- Johnson and Johnson
- LEO Pharma AS
- Livzon Pharmaceutical Group Inc.
- Novartis AG
- Pfizer Inc.
- RPG Life Sciences Ltd.
- Sebela Pharmaceuticals Inc.
- TFF Pharmaceuticals Inc.
- Viatris Inc. are some of the major market participants
Access additional Vendor Profiles for Strategic Moves and their Product offerings, Download Sample Now!
Immunosuppressants Market 2022-2026: Key Highlights
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will assist immunosuppressants market growth during the next five years
- Estimation of the immunosuppressants market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the immunosuppressants market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of immunosuppressants market vendors
- Biosensors in Life Sciences market by Application and Geography – Forecast and Analysis – 2021 – 2025
- Life Sciences Analytics Market by End-user, Deployment, and Geography – Forecast and Analysis – 2021 – 2025
Immunosuppressants Market Scope
Growth momentum & CAGR
Accelerate at a CAGR of 7.73%
Market growth 2022-2026
USD 6.99 billion
YoY growth (%)
North America, Europe, Asia, and Rest of World (ROW)